A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy
- PMID: 35641353
- DOI: 10.1016/j.nmd.2022.03.008
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy
Abstract
Muscle Glycogenosis type 0 (GSD0B) is an extremely rare disorder first recognized in 2007 in three siblings with childhood onset and severe cardiomyopathy. Since then, a few cases with severe cardiac involvement and premature death have been reported. We describe two unrelated cases presenting with an adult-onset myopathy with no heart involvement. Clinical features were quite similar in both patients, mainly characterized by early fatigability, myalgia and muscle weakness. Muscle biopsy revealed marked glycogen depletion in nearly all myofibers. Biochemical assay demonstrated a marked reduction of Glycogen Synthase (GS) activity. Sequence analysis of GYS1 revealed two new variants: a homozygous G to C substitution in the splice donor consensus site (c.678+1G>C) in patient1 and a homozygous missense variant c.630G>C in exon 3 (p. Asp145His) in patient 2. This study describes a new phenotype of muscle GSD0B presenting with adult onset, proximal myopathy, no cardiac abnormalities and a quite benign disease course. This report highlights the importance of a systematic diagnostic approach that includes muscle morphology and enzymatic assay to facilitate the identification of adult patients with GSD0B.
Keywords: GSD0B; Metabolic myopathy; Muscle glycogenosis; Muscle morphologic studies; Muscle weakness.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest All other authors report no disclosures.
Similar articles
-
Expanding the clinical phenotype and understanding the biochemical consequences of Muscle Glycogen Synthase Deficiency (GSD0B).Mol Genet Metab. 2025 Jul;145(3):109140. doi: 10.1016/j.ymgme.2025.109140. Epub 2025 May 18. Mol Genet Metab. 2025. PMID: 40398079
-
Muscle glycogen storage disease 0 presenting recurrent syncope with weakness and myalgia.Neuromuscul Disord. 2012 Feb;22(2):162-5. doi: 10.1016/j.nmd.2011.08.008. Epub 2011 Sep 29. Neuromuscul Disord. 2012. PMID: 21958591
-
Functional characterization of GYG1 variants in two patients with myopathy and glycogenin-1 deficiency.Neuromuscul Disord. 2019 Dec;29(12):951-960. doi: 10.1016/j.nmd.2019.10.002. Epub 2019 Oct 23. Neuromuscul Disord. 2019. PMID: 31791869
-
Lipid-storage myopathy with glycogen storage disease gene mutations mimicking polymyositis: a case report and review of the literature.J Int Med Res. 2022 Mar;50(3):3000605221084873. doi: 10.1177/03000605221084873. J Int Med Res. 2022. PMID: 35296144 Free PMC article. Review.
-
Glycogen storage myopathies.Neurol Clin. 2000 Feb;18(1):125-50. doi: 10.1016/s0733-8619(05)70181-x. Neurol Clin. 2000. PMID: 10658171 Review.
Cited by
-
Neurological glycogen storage diseases and emerging therapeutics.Neurotherapeutics. 2024 Sep;21(5):e00446. doi: 10.1016/j.neurot.2024.e00446. Epub 2024 Sep 14. Neurotherapeutics. 2024. PMID: 39277505 Free PMC article. Review.
-
Glycogen storage diseases.Nat Rev Dis Primers. 2023 Sep 7;9(1):46. doi: 10.1038/s41572-023-00456-z. Nat Rev Dis Primers. 2023. PMID: 37679331 Review.
-
Cardiovascular involvement in glycogen storage diseases.Nat Rev Cardiol. 2025 Jun 5. doi: 10.1038/s41569-025-01171-w. Online ahead of print. Nat Rev Cardiol. 2025. PMID: 40473899 Review.
-
Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs).Biomolecules. 2024 Sep 1;14(9):1096. doi: 10.3390/biom14091096. Biomolecules. 2024. PMID: 39334863 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical